PharmaBlock Sciences Nanjing Inc
SZSE:300725

Watchlist Manager
PharmaBlock Sciences Nanjing Inc Logo
PharmaBlock Sciences Nanjing Inc
SZSE:300725
Watchlist
Price: 35.4 CNY
Market Cap: 7B CNY
Have any thoughts about
PharmaBlock Sciences Nanjing Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
PharmaBlock Sciences Nanjing Inc

Current Assets 2.5B
Cash & Short-Term Investments 1.2B
Receivables 406.1m
Other Current Assets 831.8m
Non-Current Assets 2.3B
Long-Term Investments 5.4m
PP&E 1.7B
Intangibles 463.9m
Other Non-Current Assets 59.3m
Current Liabilities 609.7m
Accounts Payable 220.7m
Accrued Liabilities 73.5m
Short-Term Debt 55.3m
Other Current Liabilities 260.2m
Non-Current Liabilities 1.2B
Long-Term Debt 1.2B
Other Non-Current Liabilities 71.8m

Balance Sheet
PharmaBlock Sciences Nanjing Inc

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
14
61
78
158
264
145
1 245
693
1 138
508
Cash
0
0
0
0
0
0
0
693
1 138
508
Cash Equivalents
14
61
78
158
264
145
1 245
0
0
0
Short-Term Investments
2
0
0
0
0
22
108
405
467
1 090
Total Receivables
13
22
30
40
40
88
171
221
341
478
Accounts Receivables
10
20
27
38
35
80
167
201
330
474
Other Receivables
4
2
3
2
5
8
4
20
11
4
Inventory
31
43
77
117
144
207
310
448
676
725
Other Current Assets
8
7
6
116
60
76
40
37
37
17
Total Current Assets
68
133
191
431
509
537
1 873
1 804
2 660
2 818
PP&E Net
28
31
75
93
126
258
309
1 173
1 661
1 753
PP&E Gross
28
31
75
93
126
258
309
1 173
1 661
1 753
Accumulated Depreciation
14
18
28
39
54
73
96
261
334
437
Intangible Assets
2
2
10
20
24
25
34
111
111
109
Goodwill
0
0
7
7
7
31
31
356
356
356
Long-Term Investments
2
2
1
1
81
154
157
9
6
5
Other Long-Term Assets
1
5
16
16
14
25
21
53
68
62
Other Assets
0
0
7
7
7
31
31
356
356
356
Total Assets
102
N/A
173
+70%
299
+73%
567
+90%
761
+34%
1 029
+35%
2 425
+136%
3 507
+45%
4 862
+39%
5 104
+5%
Liabilities
Accounts Payable
3
7
14
19
29
31
56
116
276
193
Accrued Liabilities
5
9
10
17
23
18
33
61
93
110
Short-Term Debt
0
0
4
1
25
156
248
531
301
322
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
10
15
370
Other Current Liabilities
6
10
12
17
76
74
138
72
54
61
Total Current Liabilities
14
26
40
55
153
278
476
789
739
1 056
Long-Term Debt
0
0
0
0
0
0
0
24
1 392
1 139
Deferred Income Tax
0
0
2
2
1
1
1
13
20
24
Minority Interest
0
1
9
8
0
0
0
200
0
0
Other Liabilities
0
0
3
7
7
9
54
54
53
53
Total Liabilities
15
N/A
27
+85%
54
+101%
72
+34%
161
+124%
288
+79%
531
+84%
1 079
+103%
2 205
+104%
2 272
+3%
Equity
Common Stock
43
50
55
73
110
145
154
200
200
200
Retained Earnings
41
19
18
85
203
333
496
967
1 261
1 439
Additional Paid In Capital
4
115
174
339
288
318
1 313
1 299
1 075
1 090
Treasury Stock
0
0
0
0
0
54
65
35
0
20
Other Equity
0
0
1
1
2
2
3
3
122
123
Total Equity
87
N/A
146
+67%
245
+68%
495
+102%
600
+21%
741
+24%
1 895
+156%
2 427
+28%
2 658
+9%
2 832
+7%
Total Liabilities & Equity
102
N/A
173
+70%
299
+73%
567
+90%
761
+34%
1 029
+35%
2 425
+136%
3 507
+45%
4 862
+39%
5 104
+5%
Shares Outstanding
Common Shares Outstanding
108
127
139
186
186
186
187
198
200
199

See Also

Discover More